Baird Medical Investment Holdings Limited (BDMD) is a Medical - Devices company in the Healthcare sector, currently trading at $1.75. It has a SharesGrow Score of 80/100, indicating a strong investment profile with 5 out of 7 criteria passed.
Valuation: BDMD trades at a trailing Price-to-Earnings (P/E) of -15.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.09.
Financials: revenue is $37M, +11.3%/yr average growth. Net income is $12M, growing at +3.2%/yr. Net profit margin is 33.6% (strong). Gross margin is 88.2% (+4.6 pp trend).
Balance sheet: total debt is $21M against $40M equity (Debt-to-Equity (D/E) ratio 0.53, moderate). Current ratio is 1.77 (strong liquidity). Debt-to-assets is 26.8%. Total assets: $78M.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 63/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 50/100 (Partial), Future ?/100 (Fail), Income 100/100 (Pass).
